C30H29F2NO9
Neat
585.56
-20°C
Room Temperature
536709-33-8; EZETIMIBE HYDROXY GLUCURONIDE; SCH 488128; E575Y24YTQ; Ezetimibe Hydroxy ?-D-Glucuronide; UNII-E575Y24YTQ; (2S, 3S, 4S, 5R, 6R)-6-[(1S)-1-(4-FLUOROPHENYL)-3-[(2S, 3R)-1-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-4-OXOAZETIDIN-3-YL]PROPOXY]-3, 4, 5-TRIHYDROXYOXANE-2-CARBOXYLIC ACID; Ezetimibe hydroxy-b-D-glucuronide; (1S)-1-(4-Fluorophenyl)-3-((2S, 3R)-1-(4-fluorophenyl)-2-(4-hydroxyphenyl)-4-oxo-3-azetidinyl)propyl beta-D-glucopyranosiduronic acid; beta-D-Glucopyranosiduronic acid, (1S)-1-(4-fluorophenyl)-3-((2S, 3R)-1-(4-fluorophenyl)-2-(4-hydroxyphenyl)-4-oxo-3-azetidinyl)propyl; SCHEMBL15805132; DTXSID00678703; MFCD08063722; Ezetimibe Hydroxy beta -D-Glucuronide; ME09937; DA-63347; HY-135245; CS-0110225; G77025; (1S)-1-(4-FLUOROPHENYL)-3-((2S and 3R)-1-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-4-OXO-3-AZETIDINYL)PROPYL .BETA.-D-GLUCOPYRANOSIDURONIC ACID
(2S, 3S, 4S, 5R, 6R)-6-[(1S)-1-(4-fluorophenyl)-3-[(2S, 3R)-1-(4-fluorophenyl)-2-(4-hydroxyphenyl)-4-oxoazetidin-3-yl]propoxy]-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
InChI=1S/C30H29F2NO9/c31-17-5-1-15(2-6-17)22(41-30-26(37)24(35)25(36)27(42-30)29(39)40)14-13-21-23(16-3-11-20(34)12-4-16)33(28(21)38)19-9-7-18(32)8-10-19/h1-12,21-27,30,34-37H,13-14H2,(H,39,40)/t21-,22+,23-,24+,25+,26-,27+,30-/m1/s1